Matisse Capital’s Fulcrum Therapeutics FULC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$180K	Sell	26,100 -70,617	-73%	-$486K	0.08%	164
2025 Q1	$279K	Sell	96,717 -31,728	-25%	-$91.4K	0.15%	142
2024 Q4	$604K	Buy	128,445 +21,728	+20%	+$102K	0.31%	98
2024 Q3	$381K	Buy	+106,717	New	+$381K	0.19%	127